SG11201507406YA - Purification of rapamycin derivatives - Google Patents
Purification of rapamycin derivativesInfo
- Publication number
- SG11201507406YA SG11201507406YA SG11201507406YA SG11201507406YA SG11201507406YA SG 11201507406Y A SG11201507406Y A SG 11201507406YA SG 11201507406Y A SG11201507406Y A SG 11201507406YA SG 11201507406Y A SG11201507406Y A SG 11201507406YA SG 11201507406Y A SG11201507406Y A SG 11201507406YA
- Authority
- SG
- Singapore
- Prior art keywords
- purification
- rapamycin derivatives
- rapamycin
- derivatives
- Prior art date
Links
- 238000000746 purification Methods 0.000 title 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361799857P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/030602 WO2014145780A1 (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507406YA true SG11201507406YA (en) | 2015-10-29 |
Family
ID=51538094
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507406YA SG11201507406YA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG10201707632PA SG10201707632PA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG10202112135VA SG10202112135VA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201707632PA SG10201707632PA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
| SG10202112135VA SG10202112135VA (en) | 2013-03-15 | 2014-03-17 | Purification of rapamycin derivatives |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US9598439B2 (https=) |
| EP (1) | EP2972258B1 (https=) |
| JP (4) | JP2016519086A (https=) |
| CN (2) | CN108864149B (https=) |
| CA (1) | CA2901162C (https=) |
| ES (1) | ES2897473T3 (https=) |
| SG (3) | SG11201507406YA (https=) |
| WO (1) | WO2014145780A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101616465B1 (ko) | 2009-11-02 | 2016-04-28 | 펄스 테라퓨틱스, 인코포레이티드 | 기자성 스테이터 시스템 및 마그네틱 로터의 무선제어 방법 |
| ES2897473T3 (es) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purificación de derivados de la rapamicina |
| CN109851626B (zh) * | 2019-01-08 | 2021-11-02 | 扬子江药业集团四川海蓉药业有限公司 | 一种替西罗莫司的分离纯化方法 |
| CN116102576B (zh) * | 2021-11-09 | 2025-08-29 | 上海博畅医疗科技有限公司 | 一种优美莫司晶体的制造方法及其应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
| US20060198867A1 (en) * | 1997-09-25 | 2006-09-07 | Abbott Laboratories, Inc. | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
| US7452692B2 (en) | 2002-02-13 | 2008-11-18 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Method for extracting a macrolide from biomatter |
| TR200500302T3 (tr) * | 2003-03-31 | 2005-04-21 | Biogal Gyogyszergyar Rt. | Makrolidlerin kristalizasyonu ve saflaştırılması. |
| US7645876B2 (en) | 2004-12-01 | 2010-01-12 | TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság | Processes for producing crystalline macrolides |
| US7220755B2 (en) * | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| RU2317991C1 (ru) * | 2003-12-05 | 2008-02-27 | Байокон Лимитид | Способ выделения и очистки макролидов |
| JP4716280B2 (ja) * | 2004-03-01 | 2011-07-06 | テルモ株式会社 | Ｏ−アルキル化ラパマイシン誘導体の製造法 |
| JP4224115B2 (ja) * | 2004-04-14 | 2009-02-12 | ワイス | ラパマイシン４２−エステル誘導体の位置特異的合成 |
| JP2008531686A (ja) * | 2005-03-02 | 2008-08-14 | ワイス | ラパマイシンの精製 |
| US20060222627A1 (en) * | 2005-03-30 | 2006-10-05 | Andrew Carter | Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| BRPI0619592A2 (pt) * | 2005-12-07 | 2016-09-06 | Wyeth Corp | métodos para medir a qualidade da partícula de um composto de rapamicina, para determinar o tamanho de partícula médio de uma amostra e a cristalinidade de um composto de rapamicina, e para a purificação de rapamicina |
| US7700614B2 (en) * | 2005-12-14 | 2010-04-20 | Abbott Laboratories | One pot synthesis of tetrazole derivatives of rapamycin |
| GB0601406D0 (en) * | 2006-01-24 | 2006-03-08 | Novartis Ag | Organic Compounds |
| MX2008011458A (es) | 2006-03-07 | 2008-09-24 | Wyeth Corp | Procedimiento para preparar conjugados de polietilenglicol solubles en agua de inmunosupresores de macrolidos. |
| US7812032B2 (en) * | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
| US7820812B2 (en) * | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
| AU2006350684B2 (en) * | 2006-11-10 | 2012-07-05 | Biocon Limited | A pure form of rapamycin and a process for recovery and purification thereof |
| WO2008065887A1 (en) * | 2006-11-27 | 2008-06-05 | Terumo Kabushiki Kaisha | Process for producing o-alkylated rapamycin derivative, and o-alkylated rapamycin derivative |
| US20080287675A1 (en) * | 2007-05-18 | 2008-11-20 | Abbott Laboratories | Cascade system |
| CN101077334A (zh) * | 2007-06-29 | 2007-11-28 | 济南康泉医药科技有限公司 | 含酪氨酸激酶抑制剂的抗癌组合物 |
| TW200948361A (en) | 2008-05-26 | 2009-12-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Method for synthesizing Biolimus A9 and the like and method for improving stability of the same |
| US20100055145A1 (en) * | 2008-08-29 | 2010-03-04 | Biosensors International Group | Stent coatings for reducing late stent thrombosis |
| EP2421571A2 (en) | 2009-04-24 | 2012-02-29 | Boston Scientific Scimed, Inc. | Use of drug polymorphs to achieve controlled drug delivery from a coated medical device |
| CN102464669B (zh) * | 2010-11-17 | 2014-04-16 | 浙江海正药业股份有限公司 | 无定形依维莫司及其制备方法 |
| WO2013022458A1 (en) | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| WO2013028208A1 (en) * | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| CN102786534A (zh) * | 2012-05-25 | 2012-11-21 | 上海现代制药股份有限公司 | 一种依维莫司的制备方法 |
| ES2897473T3 (es) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purificación de derivados de la rapamicina |
-
2014
- 2014-03-17 ES ES14763326T patent/ES2897473T3/es active Active
- 2014-03-17 CN CN201811056060.XA patent/CN108864149B/zh active Active
- 2014-03-17 JP JP2016503426A patent/JP2016519086A/ja not_active Withdrawn
- 2014-03-17 CA CA2901162A patent/CA2901162C/en active Active
- 2014-03-17 CN CN201480013252.6A patent/CN105102967B/zh active Active
- 2014-03-17 SG SG11201507406YA patent/SG11201507406YA/en unknown
- 2014-03-17 SG SG10201707632PA patent/SG10201707632PA/en unknown
- 2014-03-17 SG SG10202112135VA patent/SG10202112135VA/en unknown
- 2014-03-17 EP EP14763326.7A patent/EP2972258B1/en active Active
- 2014-03-17 WO PCT/US2014/030602 patent/WO2014145780A1/en not_active Ceased
-
2015
- 2015-09-14 US US14/853,711 patent/US9598439B2/en active Active
-
2017
- 2017-02-02 US US15/422,593 patent/US10202402B2/en active Active
-
2018
- 2018-12-18 US US16/224,140 patent/US10597406B2/en active Active
-
2019
- 2019-03-07 JP JP2019041615A patent/JP2019089848A/ja active Pending
-
2020
- 2020-03-02 US US16/806,770 patent/US11046711B2/en active Active
-
2021
- 2021-05-06 JP JP2021078418A patent/JP2021121601A/ja active Pending
- 2021-06-28 US US17/360,973 patent/US11780850B2/en active Active
-
2023
- 2023-08-25 JP JP2023136964A patent/JP2023164476A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN105102967A (zh) | 2015-11-25 |
| US20190256527A1 (en) | 2019-08-22 |
| US20220024947A1 (en) | 2022-01-27 |
| JP2016519086A (ja) | 2016-06-30 |
| US20160002262A1 (en) | 2016-01-07 |
| US9598439B2 (en) | 2017-03-21 |
| HK1218959A1 (zh) | 2017-03-17 |
| US11780850B2 (en) | 2023-10-10 |
| WO2014145780A1 (en) | 2014-09-18 |
| US20170334928A1 (en) | 2017-11-23 |
| US20200270272A1 (en) | 2020-08-27 |
| US10597406B2 (en) | 2020-03-24 |
| SG10202112135VA (en) | 2021-12-30 |
| CN108864149A (zh) | 2018-11-23 |
| CA2901162A1 (en) | 2014-09-18 |
| JP2021121601A (ja) | 2021-08-26 |
| EP2972258A1 (en) | 2016-01-20 |
| EP2972258A4 (en) | 2016-12-21 |
| CN108864149B (zh) | 2022-04-05 |
| WO2014145780A4 (en) | 2014-11-20 |
| JP2019089848A (ja) | 2019-06-13 |
| ES2897473T3 (es) | 2022-03-01 |
| CA2901162C (en) | 2021-06-01 |
| US11046711B2 (en) | 2021-06-29 |
| SG10201707632PA (en) | 2017-11-29 |
| JP2023164476A (ja) | 2023-11-10 |
| US10202402B2 (en) | 2019-02-12 |
| CN105102967B (zh) | 2018-10-12 |
| EP2972258B1 (en) | 2021-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL242453B (en) | Bipyrazole derivatives as jak inhibitors | |
| PL2803401T3 (pl) | Oczyszczanie powietrza | |
| IL240863A0 (en) | Amatoxin derivatives | |
| LT2953944T (lt) | Piridazinono amidų dariniai | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| ZA201602198B (en) | Preparation of hydroxy-benzylbenzene derivatives | |
| ZA201604502B (en) | Use of benzimidazole-proline derivatives | |
| PL3027598T3 (pl) | Pochodne oksochinazolinylo-butanoamidowe | |
| ZA201602831B (en) | Use of lactones | |
| HUE037606T2 (hu) | Imidazopirazinon-származékok | |
| SG10201707632PA (en) | Purification of rapamycin derivatives | |
| SG11201505719TA (en) | Low temperature synthesis of rapamycin derivatives | |
| GB201314581D0 (en) | Purification |